Table 1: List of p53 responsive genes (n = 37). 26 genes were up-regulated and 11 genes were down-regulated in the TGCT cells following cisplatin exposure; A) 26 p53 target genes that are up-regulated in TGCT cells and down-regulated in HCT116 cells

Table 4: Terminal differentiation or senescence related genes (n = 29) induced in TGCT cells following cisplatin exposure

Figure 4. Hierarchical clustering analysis of 79 genes. These genes have been identified as being commonly expressed in microarray data from GSE1818  and in our SAM identified genes.

Table 3: List of apoptosis-related genes (n = 24). 15 up-regulated and 9 down-regulated genes in TGCT cells following cisplatin exposure; B) 9 apoptosis-related genes that are down-regulated in TGCT cells and up-regulated in HCT116 cells

24 Down-Regulated Genes in Both Bxpc-3 and PANC-1 Cells Treated by Bortezomib Compared with Control (at Least 5-Fold Greater)

Table 4. 44 Up-Regulated Genes in Both Bxpc-3 and PANC-1 Cells Treated by Bortezomib Compared with Control (at Least 3-Fold Greater)

Table 1B Genes down-regulated ò1.5-fold in NPM-ALK+ and TPM3-ALK+ ALCLs

Table 1A Genes up-regulated >1.5-fold in both NPM-ALK+ and TPM3-ALK+ ALCLs

Table 2. List of 85 genes whose transcript levels showed the highest coefficient of variation and 4-fold differences among samples

Table S1. List of all genes with a significantly changed expression level after the knockdown of NIPP1  as determined by SAM analysis (P< 0.05).

Table S2 List of all genes with a significantly changed expression level after the knockdown of EZH2  as determined by SAM analysis (P< 0.05)

Table 1. Mapping of NIPP1 target regions by a ChIP on chip  using CGH-1Mb-3K-2 arrays

Supplementary Table S2a The top 200 probe sets differentially expressed in pre-B ALL  compared to CD34+ cells. Genes up-regulated in pre-B ALL

Supplementary Table S2b The top 200 probe sets differentially expressed in pre-B ALL  compared to CD34+ cells. Genes down-regulated in pre-B ALL

Supplementary Table S3a The top 200 probe sets differentially expressed in pre-B ALL  compared to CD19+IgM- cells. Genes up-regulated in pre-B ALL